Deborah Helmstetter
Family · Fort Worth, TXNPI 1902221815
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$774
- AstraZeneca$729
- Kowa Pharmaceuticals America, Inc.$551
- Boehringer Ingelheim$498
- Novo Nordisk$263
- Novartis$229
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,99497%
- Education$1493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 54 | $774 |
| AstraZeneca(2 entities) | 39 | $729 |
| Kowa Pharmaceuticals America, Inc. | 54 | $551 |
| Boehringer Ingelheim | 25 | $498 |
| Novo Nordisk | 16 | $263 |
| Novartis | 11 | $229 |
| GSK | 10 | $225 |
| AbbVie | 13 | $215 |
| Esperion Therapeutics, Inc. | 11 | $213 |
| Lilly USA, LLC | 14 | $210 |
| Sanofi-aventis U.S. LLC | 9 | $179 |
| Astellas Pharma US Inc | 4 | $148 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $141 |
| Pfizer | 4 | $127 |
| Bayer | 5 | $80 |
| Currax Pharmaceuticals LLC | 4 | $78 |
| Dexcom, Inc. | 4 | $70 |
| Renalytix AI, Inc. | 3 | $70 |
| Merck | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| IBSA Pharma Inc. | 3 | $55 |
| Shield Therapeutics Inc | 1 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Medtronic | 1 | $21 |
| Abbott | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Genentech USA, Inc. | 1 | $8 |
How this compares
$5,143 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 14 | $300 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Worth
- Laura MoeFort Worth$158K
- Julie TaylorFort Worth$63K
- Ryan BourgeoisFort Worth$37K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.